Home ETF List About

Portfolio Holdings Detail for ISIN IE000G2LIHG9
Stock Name / FundiShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity Type
Entity LEI 549300ZP07LMR36K1T02
ETF TickerSAUA(EUR) ETF Plus

Holdings detail for EW

Stock NameEdwards Lifesciences Corp
TickerEW(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS28176E1082
LEIYA13X31F3V31L8TMPR58

Show aggregate EW holdings

News associated with EW

Edwards Lifesciences (NYSE:EW) Cut to Buy at Wall Street Zen
Edwards Lifesciences (NYSE:EW – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. A number of other research analysts have also issued reports on the company. Wells Fargo & Company boosted their price objective on Edwards Lifesciences […] - 2025-09-15 05:40:50
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings
Key PointsKen Griffin founded the hedge fund firm Citadel. - 2025-09-09 12:44:48
Top Stock Reports for Apple, Novartis & Charles Schwab
Apple grows Services to 1B+ paid subscribers, while Novartis lifts guidance and Schwab rides higher rates to asset gains. - 2025-09-04 17:29:00
Atria Wealth Solutions Inc. Sells 29,763 Shares of Edwards Lifesciences Corporation (NYSE:EW)
Atria Wealth Solutions Inc. cut its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 81.7% during the 1st quarter, HoldingsChannel reports. The firm owned 6,662 shares of the medical research company’s stock after selling 29,763 shares during the period. Atria Wealth Solutions Inc.’s holdings in Edwards Lifesciences were worth $483,000 as […] - 2025-08-14 05:04:55
Edwards Lifesciences (NYSE:EW) Raised to Buy at BTIG Research
Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $100.00 target price on the medical research company’s stock. BTIG Research’s price target points to a potential […] - 2025-07-31 03:02:52
Edwards Lifesciences (NYSE:EW) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday. Several other research analysts have also weighed in on EW. Wells Fargo & Company lifted their price objective on Edwards Lifesciences from $80.00 to $84.00 and […] - 2025-07-29 02:58:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 13:25:48
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 12:26:28
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 09:49:10
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 08:57:30
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 07:43:41
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 04:16:07
Edwards Lifesciences (NYSE:EW) Price Target Raised to $82.00
Edwards Lifesciences (NYSE:EW – Free Report) had its price objective upped by Truist Financial from $81.00 to $82.00 in a research note published on Friday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other research firms have also weighed in on EW. Wall Street Zen lowered shares […] - 2025-07-28 04:08:50
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
Edwards Lifesciences (NYSE:EW – Free Report) had its price target increased by JPMorgan Chase & Co. from $80.00 to $85.00 in a report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other brokerages also recently issued reports on EW. Wells Fargo & […] - 2025-07-28 04:08:48
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00
Edwards Lifesciences (NYSE:EW – Free Report) had its price target raised by Barclays from $90.00 to $95.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight rating on the medical research company’s stock. A number of other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price […] - 2025-07-28 02:46:53
Stifel Nicolaus Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price
Edwards Lifesciences (NYSE:EW – Free Report) had its target price upped by Stifel Nicolaus from $90.00 to $95.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. EW has been the topic of several other research reports. Evercore ISI increased […] - 2025-07-28 02:46:53
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says
Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Robert W. Baird from $78.00 to $79.00 in a research report report published on Friday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Evercore ISI […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Price Target Raised to $80.00
Edwards Lifesciences (NYSE:EW – Free Report) had its target price lifted by Evercore ISI from $77.00 to $80.00 in a research report report published on Friday,Benzinga reports. The firm currently has an in-line rating on the medical research company’s stock. A number of other brokerages have also issued reports on EW. Argus upgraded shares of […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Edwards Lifesciences (NYSE:EW – Free Report) had its price objective lifted by Wells Fargo & Company from $80.00 to $84.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. A number of other research analysts also recently commented on EW. Dbs Bank raised shares […] - 2025-07-28 02:46:49
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price
Edwards Lifesciences (NYSE:EW – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $85.00 to $94.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities analysts have also issued reports on EW. Dbs Bank upgraded […] - 2025-07-28 02:46:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 02:37:03
Solid Corporate Earnings Results Support Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 19:42:53
Solid Corporate Earnings Results Support Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:56:19
Positive Earnings Results Lift Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 14:23:43
Solid Corporate Earnings Results Support Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:18:44
Positive Earnings Results Lift Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 12:39:11
J.W. Cole Advisors Inc. Has $814,000 Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW)
J.W. Cole Advisors Inc. raised its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 220.2% in the 1st quarter, HoldingsChannel reports. The fund owned 11,224 shares of the medical research company’s stock after acquiring an additional 7,719 shares during the period. J.W. Cole Advisors Inc.’s holdings in Edwards Lifesciences were worth $814,000 at […] - 2025-07-25 05:12:50
Sigma Planning Corp Has $294,000 Position in Edwards Lifesciences Corporation (NYSE:EW)
Sigma Planning Corp boosted its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 4.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,055 shares of the medical research company’s stock after acquiring an additional 191 shares during the quarter. Sigma Planning Corp’s holdings in Edwards Lifesciences were worth $294,000 as of its […] - 2025-07-21 05:06:55
Edwards Lifesciences Corporation (NYSE:EW) Position Lowered by Ballentine Partners LLC
Ballentine Partners LLC decreased its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 375 shares during the period. Ballentine Partners LLC’s holdings […] - 2025-07-16 06:51:32
Alps Advisors Inc. Purchases Shares of 5,090 Edwards Lifesciences Corporation (NYSE:EW)
Alps Advisors Inc. bought a new position in Edwards Lifesciences Corporation (NYSE:EW – Free Report) during the 1st quarter, HoldingsChannel reports. The fund bought 5,090 shares of the medical research company’s stock, valued at approximately $369,000. A number of other hedge funds have also recently added to or reduced their stakes in the stock. Norges […] - 2025-07-16 06:01:07

iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc) EW holdings

DateNumber of EW Shares HeldBase Market Value of EW SharesLocal Market Value of EW SharesChange in EW Shares HeldChange in EW Base ValueCurrent Price per EW Share HeldPrevious Price per EW Share Held
2025-09-29 (Monday)178,131USD 13,749,932USD 13,749,932
2025-09-26 (Friday)177,390EW holding increased by 1668USD 13,525,988EW holding increased by 299393USD 13,525,9881,668USD 299,393 USD 76.25 USD 75.27
2025-09-25 (Thursday)175,722EW holding increased by 117USD 13,226,595EW holding increased by 115926USD 13,226,595117USD 115,926 USD 75.27 USD 74.66
2025-09-24 (Wednesday)175,605EW holding increased by 2216USD 13,110,669EW holding increased by 184519USD 13,110,6692,216USD 184,519 USD 74.66 USD 74.55
2025-09-18 (Thursday)173,389EW holding increased by 468USD 12,926,150EW holding decreased by -77509USD 12,926,150468USD -77,509 USD 74.55 USD 75.2
2025-09-17 (Wednesday)172,921EW holding increased by 585USD 13,003,659EW holding increased by 62949USD 13,003,659585USD 62,949 USD 75.2 USD 75.09
2025-09-16 (Tuesday)172,336EW holding increased by 936USD 12,940,710EW holding decreased by -94260USD 12,940,710936USD -94,260 USD 75.09 USD 76.05
2025-09-15 (Monday)171,400EW holding increased by 304USD 13,034,970EW holding decreased by -236947USD 13,034,970304USD -236,947 USD 76.05 USD 77.57
2025-09-12 (Friday)171,096USD 13,271,917EW holding decreased by -75282USD 13,271,9170USD -75,282 USD 77.57 USD 78.01
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EW by Blackrock for IE000G2LIHG9

Show aggregate share trades of EW

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-26BUY1,668 76.250* 73.31
2025-09-25BUY117 75.270* 73.30
2025-09-24BUY2,216 74.660* 73.29
2025-09-18BUY468 74.550* 73.28
2025-09-17BUY585 75.200* 73.27
2025-09-16BUY936 75.090* 73.26
2025-09-15BUY304 76.050* 73.25
2025-09-11SELL-38 78.010* 73.20 Profit of 2,782 on sale
2025-09-10BUY2,432 78.280* 73.18
2025-09-09BUY152 79.800* 73.14
2025-08-06BUY716 78.610* 73.09
2025-07-31BUY195 79.310* 73.02
2025-07-29BUY780 80.470* 72.94
2025-07-28BUY148 78.490* 72.91
2025-07-25BUY234 80.000* 72.87
2025-07-24BUY114 75.800* 72.85
2025-07-23BUY273 76.910* 72.83
2025-07-22BUY156 76.300* 72.81
2025-07-18BUY280 76.490* 72.79
2025-07-17BUY234 76.180* 72.77
2025-07-11BUY312 78.050* 72.67
2025-07-10BUY351 78.800* 72.63
2025-07-09BUY351 77.190* 72.61
2025-07-07SELL-234 76.690* 72.56 Profit of 16,980 on sale
2025-07-02SELL-958 77.020* 72.49 Profit of 69,441 on sale
2025-06-27BUY122 78.210* 72.42
2025-06-26BUY117 77.150* 72.39
2025-06-24SELL-546 75.850* 72.34 Profit of 39,497 on sale
2025-06-18BUY312 73.980* 72.29
2025-06-17BUY117 73.270* 72.28
2025-06-16SELL-159 74.820* 72.27 Profit of 11,491 on sale
2025-06-13BUY342 75.150* 72.25
2025-06-12SELL-195 75.890* 72.23 Profit of 14,084 on sale
2025-06-11BUY413 75.470* 72.20
2025-06-06BUY117 77.520* 72.12
2025-06-05BUY546 77.770* 72.08
2025-06-04BUY76 77.850* 72.04
2025-06-03SELL-38 77.720* 72.00 Profit of 2,736 on sale
2025-05-30SELL-4,636 78.220* 71.92 Profit of 333,416 on sale
2025-05-29BUY106 77.730* 71.88
2025-05-27BUY652 76.220* 71.81
2025-05-23BUY540 74.990* 71.77
2025-05-22BUY266 74.790* 71.75
2025-05-19BUY228 78.040* 71.63
2025-05-16BUY114 78.000* 71.58
2025-05-15SELL-76 76.880* 71.54 Profit of 5,437 on sale
2025-05-14BUY38 76.750* 71.50
2025-05-13BUY76 75.500* 71.47
2025-05-08BUY76 74.630* 71.45
2025-05-07BUY114 75.040* 71.42
2025-05-02BUY4,218 75.650* 71.33
2025-04-30BUY1,330 75.490* 71.27
2025-04-29BUY333 76.280* 71.23
2025-04-28BUY266 75.540* 71.19
2025-04-25BUY684 76.040* 71.15
2025-04-24SELL-798 75.130* 71.12 Profit of 56,754 on sale
2025-04-23BUY722 70.460* 71.13
2025-04-22BUY304 70.600* 71.13
2025-04-17BUY418 71.530* 71.14
2025-04-15BUY380 70.760* 71.14
2025-04-11BUY608 69.400* 71.17
2025-04-09BUY228 69.900* 71.21
2025-04-08BUY1,368 67.070* 71.24
2025-04-07BUY450 69.000* 71.26
2025-04-04SELL-608 69.360* 71.28 Profit of 43,340 on sale
2025-04-02BUY5,168 72.050* 71.28
2025-04-01BUY38 71.870* 71.27
2025-03-31BUY266 72.480* 71.26
2025-03-28BUY152 70.910* 71.26
2025-03-27BUY72 71.190* 71.26
2025-03-26BUY38 71.090* 71.26
2025-03-25BUY418 71.240* 71.26
2025-03-24BUY468 71.350* 71.26
2025-03-21SELL-152 70.460* 71.27 Profit of 10,833 on sale
2025-03-20BUY608 70.950* 71.27
2025-03-19BUY108 70.900* 71.28
2025-03-18BUY1,328 70.340* 71.29
2025-03-17BUY266 70.630* 71.30
2025-03-14BUY1,976 69.290* 71.32
2025-03-13BUY380 67.950* 71.35
2025-03-12SELL-1,900 68.510* 71.38 Profit of 135,629 on sale
2025-03-11SELL-1,406 68.390* 71.42 Profit of 100,412 on sale
2025-03-10BUY418 68.530* 71.45
2025-03-07BUY76 70.330* 71.46
2025-03-05BUY570 72.850* 71.45
2025-03-04BUY646 71.380* 71.45
2025-03-03BUY1,216 71.390* 71.45
2025-02-28BUY988 71.620* 71.44
2025-02-27SELL-190 71.400* 71.45 Profit of 13,575 on sale
2025-02-25BUY1,406 71.450* 71.44
2025-02-21BUY152 73.300* 71.40
2025-02-18SELL-342 75.670* 71.26 Profit of 24,370 on sale
2025-02-14SELL-2,318 76.190* 71.13 Profit of 164,872 on sale
2025-02-13BUY38 76.000* 71.06
2025-02-12BUY374 75.820* 71.00
2025-02-07SELL-53 70.350* 71.00 Profit of 3,763 on sale
2025-02-06BUY722 70.990* 71.01
2025-02-05BUY190 72.100* 70.99
2025-02-04BUY228 71.330* 70.98
2025-02-03BUY228 71.380* 70.98
2025-01-31BUY418 72.450* 70.96
2025-01-29SELL-38 71.130* 70.92 Profit of 2,695 on sale
2025-01-28SELL-342 72.560* 70.89 Profit of 24,244 on sale
2025-01-27SELL-608 69.200* 70.92 Profit of 43,118 on sale
2025-01-24BUY456 68.990* 70.95
2025-01-23BUY76 68.930* 70.98
2025-01-22BUY625 69.040* 71.02
2025-01-21BUY456 69.970* 71.04
2025-01-16BUY703 69.860* 71.10
2025-01-14BUY304 71.040* 71.12
2025-01-10BUY912 73.420* 71.08
2024-12-30BUY114 74.240* 70.77
2024-12-27BUY152 75.650* 70.66
2024-12-23BUY1,140 74.810* 70.31
2024-12-20BUY304 74.810* 70.20
2024-12-19BUY38 73.930* 70.11
2024-12-18BUY304 72.810* 70.03
2024-12-17BUY76 74.120* 69.92
2024-12-16BUY380 73.910* 69.81
2024-12-13BUY274 73.320* 69.71
2024-12-10BUY1,900 73.390* 69.48
2024-12-09BUY228 70.900* 69.43
2024-12-06SELL-570 71.530* 69.37 Profit of 39,539 on sale
2024-12-05SELL-38 72.430* 69.26 Profit of 2,632 on sale
2024-12-03BUY190 70.200* 69.05
2024-11-27SELL-228 72.070* 68.65 Profit of 15,651 on sale
2024-11-26BUY798 71.550* 68.52
2024-11-25BUY100 71.270* 68.39
2024-11-22SELL-72 70.480* 68.30 Profit of 4,917 on sale
2024-11-21SELL-190 70.380* 68.19 Profit of 12,956 on sale
2024-11-20SELL-76 69.540* 68.12 Profit of 5,177 on sale
2024-11-19BUY38 70.200* 68.00
2024-11-18BUY328 69.890* 67.89
2024-11-11BUY114 66.700* 68.11
2024-11-07BUY106 65.840* 68.43
2024-11-06BUY912 65.750* 68.66
2024-11-05BUY190 66.690* 68.83
2024-11-04BUY74 66.470* 69.07
2024-11-01BUY108 67.540* 69.24
2024-10-30SELL-228 68.630* 69.65 Profit of 15,879 on sale
2024-10-29SELL-684 69.370* 69.69 Profit of 47,669 on sale
2024-10-28SELL-266 68.520* 69.93 Profit of 18,600 on sale
2024-10-21SELL-38 70.050* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EW

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19406,40201,881,72721.6%
2025-09-18684,5201,1773,487,98119.6%
2025-09-17484,3222101,603,06530.2%
2025-09-16811,9538562,055,93739.5%
2025-09-15611,0121041,391,88243.9%
2025-09-12982,9281,1002,234,22744.0%
2025-09-11514,2348281,919,00926.8%
2025-09-10669,7051491,567,94142.7%
2025-09-09441,4930925,37547.7%
2025-09-08632,5876721,251,93950.5%
2025-09-05334,037300934,00635.8%
2025-09-04380,3180871,93143.6%
2025-09-03701,9434591,170,96659.9%
2025-09-02397,396531,208,87232.9%
2025-08-29397,628800844,31847.1%
2025-08-28604,08741,056,65357.2%
2025-08-27493,608822875,88656.4%
2025-08-26480,2680868,21355.3%
2025-08-25796,55601,181,25867.4%
2025-08-22552,73911,011,67854.6%
2025-08-21873,0447981,597,74254.6%
2025-08-20847,84738,6991,560,10554.3%
2025-08-19613,349331,256,57748.8%
2025-08-18668,7194391,642,75940.7%
2025-08-15369,455513826,72344.7%
2025-08-14514,2026,112864,59359.5%
2025-08-13567,8572991,347,26442.1%
2025-08-12547,77312,3161,428,27738.4%
2025-08-11487,82301,152,63042.3%
2025-08-08661,697201,224,45854.0%
2025-08-07669,9319821,297,46951.6%
2025-08-06880,0284131,551,65956.7%
2025-08-05661,93381,592,64941.6%
2025-08-04572,1652681,310,04443.7%
2025-08-01678,0285,6001,308,86351.8%
2025-07-31831,4012491,817,97545.7%
2025-07-301,305,0166932,481,80852.6%
2025-07-291,129,154582,399,22347.1%
2025-07-28684,1012,1112,276,89230.0%
2025-07-251,669,7529206,616,25925.2%
2025-07-24455,59302,607,89817.5%
2025-07-23444,64501,978,11022.5%
2025-07-22447,8835112,702,92516.6%
2025-07-21568,293271,249,72745.5%
2025-07-18590,448592,118,40227.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.